Related Experiment Videos
[Role of angioplasty in acute myocardial infarction]
1Servicio de Cardiología, Hospital Clínic i Provincial de Barcelona, Universidad de Barcelona.
Insights
Primary angioplasty for acute myocardial infarction effectively opens arteries but doesn't improve survival and may increase complications. It is best reserved for specific patients or when thrombolytic therapy is contraindicated or ineffective.
Area of Science:
- Cardiology
- Interventional Cardiology
Background:
- Angioplasty is effective in restoring arterial patency for acute myocardial infarction.
- High rates of reocclusion and restenosis remain a concern with angioplasty.
- Comparative trials show no survival benefit of angioplasty over thrombolysis, with increased complications.
Purpose of the Study:
- To evaluate the efficacy and safety of angioplasty in acute myocardial infarction.
- To compare angioplasty with thrombolytic therapy in terms of survival and complications.
- To identify subgroups of patients who may benefit from primary angioplasty.
Main Methods:
- Review of prospective randomized trials comparing angioplasty and thrombolytic therapy.
- Analysis of survival rates and acute complications in treated patients.
- Subgroup analysis for patients with cardiogenic shock or contraindications to thrombolysis.
Main Results:
- Angioplasty restores arterial patency and reduces stenosis.
- No significant improvement in survival was observed with angioplasty compared to thrombolysis.
- Angioplasty was associated with an excess of acute complications in some trials.
- Primary angioplasty may be beneficial in selected subgroups, such as those in cardiogenic shock.
Conclusions:
- Primary angioplasty in acute myocardial infarction should be limited to specific patient populations.
- It is recommended for patients where thrombolytic therapy is harmful or ineffective.
- Further studies are needed to define the role of rescue angioplasty.
Abstract:
Angioplasty as the treatment of acute myocardial infarction has proven to be effective in restoring arterial patency and in reducing residual stenosis, although reocclusion and restenosis may be high. Despite the good results reported by several investigators none of the prospective randomized trials comparing thrombolytic therapy with angioplasty (either alone or associated to thrombolysis) has shown any improvement in survival, the latter strategy being associated with an excess of acute complications. However, primary angioplasty may be useful in selected subgroups such as those with cardiogenic shock or with absolute contraindications for thrombolysis. The role of rescue angioplasty still needs to be defined in properly designed studies. In conclusion, primary angioplasty in acute myocardial infarction should be restricted to patients in whom thrombolytic therapy has been shown to be harmful or ineffective.